Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,941 | 843 | 93.5% |
| Education | $540.76 | 10 | 3.4% |
| Consulting Fee | $350.00 | 1 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150.00 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,980 | 87 | $0 (2024) |
| ABBVIE INC. | $1,545 | 110 | $0 (2024) |
| Janssen Biotech, Inc. | $1,528 | 116 | $0 (2024) |
| PFIZER INC. | $996.41 | 58 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $917.09 | 56 | $0 (2024) |
| GENZYME CORPORATION | $820.68 | 39 | $0 (2024) |
| Galderma Laboratories, L.P. | $777.09 | 38 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $760.89 | 50 | $0 (2024) |
| LEO Pharma Inc. | $672.63 | 36 | $0 (2024) |
| Lilly USA, LLC | $619.38 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,768 | 159 | Janssen Biotech, Inc. ($553.84) |
| 2023 | $2,732 | 156 | ABBVIE INC. ($468.50) |
| 2022 | $2,192 | 160 | ABBVIE INC. ($402.01) |
| 2021 | $1,468 | 86 | Novartis Pharmaceuticals Corporation ($349.53) |
| 2020 | $1,337 | 73 | Galderma Laboratories, L.P. ($259.19) |
| 2019 | $2,146 | 86 | Novartis Pharmaceuticals Corporation ($348.47) |
| 2018 | $1,848 | 63 | Allergan Inc. ($296.05) |
| 2017 | $1,491 | 72 | Novartis Pharmaceuticals Corporation ($325.58) |
All Payment Transactions
855 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Dermatology | ||||||
| 12/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Inflammation & Immunology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.85 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.62 | General |
| 11/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $26.33 | General |
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Immunology | ||||||
| 10/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: DERMATOLOGY | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,928 | 2,949 | $282,606 | $144,855 |
| 2022 | 17 | 1,843 | 7,547 | $281,012 | $144,011 |
| 2021 | 19 | 1,768 | 7,218 | $268,089 | $141,432 |
| 2020 | 16 | 1,704 | 2,450 | $252,428 | $120,443 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 621 | 889 | $80,010 | $54,189 | 67.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 320 | 391 | $66,470 | $32,784 | 49.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 188 | 204 | $32,640 | $12,940 | 39.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 245 | 324 | $37,260 | $12,121 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 71 | $9,230 | $5,469 | 59.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 73 | 73 | $10,950 | $5,351 | 48.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 17 | $7,820 | $4,091 | 52.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 84 | 96 | $6,240 | $3,829 | 61.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 167 | 678 | $8,136 | $3,676 | 45.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 23 | $5,865 | $3,140 | 53.5% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 26 | 27 | $4,860 | $2,595 | 53.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 35 | 35 | $2,975 | $1,482 | 49.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $4,615 | $1,330 | 28.8% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 12 | 12 | $2,400 | $1,119 | 46.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 17 | $1,530 | $405.28 | 26.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 28 | $840.00 | $292.25 | 34.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 51 | $765.00 | $40.57 | 5.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 602 | 848 | $76,320 | $49,219 | 64.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 285 | 356 | $60,760 | $28,786 | 47.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 181 | 207 | $33,120 | $13,319 | 40.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 236 | 309 | $35,535 | $11,396 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 76 | $9,880 | $6,226 | 63.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 83 | 83 | $12,450 | $6,162 | 49.5% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2022 | 16 | 4,800 | $8,400 | $6,043 | 71.9% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2022 | 16 | 24 | $8,400 | $5,882 | 70.0% |
About Dr. Adrienne Feasel, M.D
Dr. Adrienne Feasel, M.D is a Dermatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982664447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adrienne Feasel, M.D has received a total of $15,982 in payments from pharmaceutical and medical device companies, with $2,768 received in 2024. These payments were reported across 855 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($14,941).
As a Medicare-enrolled provider, Feasel has provided services to 7,243 Medicare beneficiaries, totaling 20,164 services with total Medicare billing of $550,741. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Austin, TX
- Active Since 03/27/2006
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1982664447
Products in Payments
- COSENTYX (Biological) $1,273
- TREMFYA (Drug) $995.99
- DUPIXENT (Biological) $917.85
- EUCRISA (Drug) $794.83
- SKYRIZI (Biological) $640.55
- RINVOQ (Biological) $506.92
- Cimzia (Drug) $456.41
- ENSTILAR (Drug) $448.51
- TALTZ (Drug) $419.73
- REMICADE (Biological) $371.90
- ILUMYA (Biological) $334.24
- Otezla (Drug) $323.13
- OPZELURA (Drug) $286.38
- COSENTYX (Drug) $277.82
- Winlevi (Drug) $273.36
- DUOBRII (Drug) $246.30
- Tremfya (Drug) $241.44
- Sotyktu (Drug) $241.32
- Ameluz (Drug) $231.08
- SOOLANTRA (Drug) $213.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Austin
Dr. Edward Lain, M.d, M.D
Dermatology — Payments: $2.3M
Daniel Carrasco, Md, MD
Dermatology — Payments: $1.2M
Dale Schaefer, Md, MD
Dermatology — Payments: $1.2M
Janet Dubois, M.d, M.D
Dermatology — Payments: $1.1M
Ms. Heidi Prather, M.d, M.D
Dermatology — Payments: $530,857
Daniel Friedmann, M.d, M.D
Dermatology — Payments: $231,608